
Keywords: ACSF, artificial CSF; APs, action potentials; AP5, (2R)-amino-5-phosphonovaleric acid; CB1, cannabinoid receptor type 1; CPu, caudate-putamen; DV, dorso-ventral; ECS, endocannabinoid system; EGTA, ethylene glycol tetraacetic acid; GHR, ghrelin; HEPES, 2-[